Hong Kong Stocks Movement | ALI HEALTH (00241) Rises Nearly 4% as Its Medical AI Product "Hydrogen Ion" Launches New "Dynamic Evidence Positioning" Feature

ALI HEALTH (00241) rose nearly 4%. As of the time of writing, the stock was up 3.9%, trading at HKD 6.92 with a turnover of HKD 506 million.

On the news front, on January 27, it was reported that ALI HEALTH's medical AI application product "Hydrogen Ion" has launched a new feature called "Dynamic Evidence Positioning."

This feature can precisely locate the specific sentences in the source text that directly support a viewpoint, while simultaneously verifying timeliness, authority, and logical consistency.

This essentially upgrades the previous AI practice of "vaguely citing a passage" in responses to "precisely pointing out which sentence, why it is credible, and whether it remains valid at this moment."

Previously, ALI HEALTH's "Hydrogen Ion" had completed its internal testing and was made available for download, indicating the product has entered the practical application stage, primarily targeting doctors in clinical and research fields.

CITIC SEC pointed out that leading pharmaceutical e-commerce platforms, ALI HEALTH and JD Health, have successively officially launched AI medical application products aimed at doctors.

It is optimistic that these leading pharmaceutical e-commerce platforms, leveraging their upstream pharmaceutical company resources, downstream consumer user base, and the AI foundational model capabilities and product expertise of their parent companies, will stand out in the ToD AI medical application field, be the first to establish a viable business model, and achieve revenue enhancement for their core businesses through AI healthcare.